首页|临床微生物检验中细菌耐药性监测分析

临床微生物检验中细菌耐药性监测分析

扫码查看
目的 观察在临床微生物检验中细菌耐药性监测的应用效果,探究细菌耐药性监测的应用价值,以促进临床用药安全性和规范性的提升.方法 对2021年1月1日-2023年1月1日福建省宁化县总医院收集的检测样本中分离出的300例致病菌进行细菌耐药性监测,并通过开展临床微生物检验了解菌株分布情况,分析细菌耐药性监测结果.结果 300例致病菌中大肠埃希菌检出率最高、占16.00%,其后依次为铜绿假单胞菌、占14.33%,肺炎克雷伯菌、占12.67%,最低为肺炎链球菌、占1.00%.细菌耐药性监测结果分析:占比前3的大肠埃希菌、铜绿假单胞菌、肺炎克雷伯菌均对头孢呋辛的耐药性最高,分别为79.17%、100.00%、52.63%,其中大肠埃希菌对美罗培南耐药性最低、占6.25%,铜绿假单胞菌对阿米卡星耐药性最低、占11.63%,肺炎克雷伯菌对亚胺培南耐药性最低、占0.00%.与其他两种致病菌相比,铜绿假单胞菌对头孢呋辛及氨曲南的耐药性最高,差异有统计学意义(P<0.05);与其他两种致病菌相比,大肠埃希菌对环丙沙星的耐药性最高,差异有统计学意义(P<0.05).结论 细菌耐药性监测在临床微生物检验中的应用效果良好,能够提升细菌检出率,全面获取耐药性变化情况,有利于临床医护人员为患者选用合适的治疗药物,值得临床推广应用.
Analysis of bacterial drug resistance monitoring in clinical microbiological testing
Objective To observe the application effect of bacterial drug resistance monitoring in clinical microbiological testing,to explore the application value of bacterial drug resistance monitoring,in order to promote the improvement of clinical medication safety and standardization.Methods The bacterial drug resistance of 300 pathogenic bacteria isolated from the testing samples collected by Fujian Province Ninghua County General Hospital from January 1,2021 to January 1,2023 was monitored,and the distribution of bacterial strains was understood through clinical microbiological testing,and the bacterial drug resistance monitoring results were analyzed.Results Among the 300 case of pathogenic bacteria,the detection rate of Escherichia coli was the highest,accounting for 16.00%,followed by Pseudomonas aeruginosa,accounting for 14.33%,Klebsiella pneumoniae,accounting for 12.67%,and the lowest was Streptococcus pneumoniae,accounting for 1.00%.Analysis of bacterial drug resistance monitoring results:Escherichia coli,Pseudomonas aeruginosa and Klebsiella pneumoniae,which accounted for the top three,had the highest drug resistance to cefuroxime,with 79.17%,100.00%and 52.63%,respectively,among them Escherichia coli had the lowest drug resistance to meropenem,accounting for 6.25%,and Pseudomonas aeruginosa had the lowest drug resistance to amikacin,accounting for 11.63%,Klebsiella pneumoniae had the lowest drug resistance to imipenem,accounting for 0.00%.Compared with the other two pathogenic bacteria,Pseudomonas aeruginosa had the highest drug resistance to cefuroxime and amtreonam,and the differences were statistically significant(P<0.05);compared with the other two pathogenic bacteria,Escherichia coli had the highest drug resistance to ciprofloxacin,and the differences were statistically significant(P<0.05).Conclusion The application effect of bacterial drug resistance monitoring in clinical microbiological testing was good,which could improve the detection rate of bacteria and comprehensively obtaining the change of drug resistance,which was conducive to the selection of appropriate treatment drugs for patients by clinical medical staff,and it was worthy of clinical promotion and application.

Microbiological testingBacterial drug resistanceClinical effect

吴茂彬、罗秀琴

展开 >

福建省宁化县总医院检验科,福建 三明 365400

微生物检验 细菌耐药性 临床效果

2024

中国城乡企业卫生
中华预防医学会 天津市职业病防治院

中国城乡企业卫生

影响因子:0.239
ISSN:1003-5052
年,卷(期):2024.39(4)
  • 8